NCT01863745 2024-08-19Nilotinib Roll-over Protocol for Patients in Novartis-sponsored Nilotinib Study and Benefiting From Nilotinib TreatmentNovartisPhase 2 Completed15 enrolled 7 charts
NCT01289028 2017-01-02Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib.NovartisPhase 3 Completed125 enrolled 11 charts